title: Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity.
abstract: Maternal obesity is associated with obesity and metabolic disorders in offspring. However, intervention strategies to reverse or ameliorate the effects of maternal obesity on offspring health are limited. Following maternal undernutrition, taurine supplementation can improve outcomes in offspring, possibly via effects on glucose homeostasis and insulin secretion. The effects of taurine in mediating inflammatory processes as a protective mechanism has not been investigated. Further, the efficacy of taurine supplementation in the setting of maternal obesity is not known. Using a model of maternal obesity, we examined the effects of maternal taurine supplementation on outcomes related to inflammation and lipid metabolism in mothers and neonates. Time-mated Wistar rats were randomised to either: 1) control : control diet during pregnancy and lactation (CON); 2) CON supplemented with 1.5% taurine in drinking water (CT); 3) maternal obesogenic diet (high fat, high fructose) during pregnancy and lactation (MO); or 4) MO supplemented with taurine (MOT). Maternal and neonatal weights, plasma cytokines and hepatic gene expression were analysed. A MO diet resulted in maternal hyperinsulinemia and hyperleptinemia and increased plasma glucose, glutamate and TNF-α concentrations. Taurine normalised maternal plasma TNF-α and glutamate concentrations in MOT animals. Both MO and MOT mothers displayed evidence of fatty liver accompanied by alterations in key markers of hepatic lipid metabolism. MO neonates displayed a pro-inflammatory hepatic profile which was partially rescued in MOT offspring. Conversely, a pro-inflammatory phenotype was observed in MOT mothers suggesting a possible maternal trade-off to protect the neonate. Despite protective effects of taurine in MOT offspring, neonatal mortality was increased in CT neonates, indicating possible adverse effects of taurine in the setting of normal pregnancy. These data suggest that maternal taurine supplementation may ameliorate the adverse effects observed in offspring following a maternal obesogenic diet but these effects are dependent upon prior maternal nutritional background.
authors.affiliation: Liggins Institute and Gravida: National Centre for Growth and Development, University of Auckland, Auckland, New Zealand.
authors.forename: Minglan
authors.initials: M
authors.lastname: Li
authors.forename: Clare M
authors.initials: CM
authors.lastname: Reynolds
authors.forename: Deborah M
authors.initials: DM
authors.lastname: Sloboda
authors.forename: Clint
authors.initials: C
authors.lastname: Gray
authors.forename: Mark H
authors.initials: MH
authors.lastname: Vickers
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D001835:Body Weight; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression; D005947:Glucose / Q000378:metabolism; D018698:Glutamic Acid / Q000097:blood; D006710:Homocysteine / Q000097:blood; D007249:Inflammation / Q000097:blood / Q000235:genetics / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D039382:Maternal Nutritional Physiological Phenomena; D009765:Obesity / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D013654:Taurine / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D006710:Homocysteine; D013654:Taurine; D018698:Glutamic Acid; D005947:Glucose